| Literature DB >> 7284686 |
Abstract
1. Continuous recording of proximal jejunal motility of conscious healthy subjects was made following ingestion of 200 mg hyoscine butylbromide (ten times the recommended therapeutic dosage). 2. There was no detectable modification of fasting or postprandial motor activity, although the therapeutic potency of the standard intravenous dose was confirmed.Entities:
Mesh:
Substances:
Year: 1981 PMID: 7284686 PMCID: PMC2071644 DOI: 10.1111/j.1476-5381.1981.tb09149.x
Source DB: PubMed Journal: Br J Pharmacol ISSN: 0007-1188 Impact factor: 8.739